Earnhardt Lisa D's Form 4 filing
Abbott Laboratories (ABT) · filed Mar 7, 2025
- Accession no.
- 0001415889-25-007453
- Filed
- Mar 7, 2025
- Trade date
- Mar 6-7, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $12.2M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Earnhardt Lisa DCIK 0001530893 | Officer (EVP AND GROUP PRESIDENT) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2025 | Common shares without par value | MOption exerciseAcquired | +91,167 | $80.98 | +$7,382,703.66 | 163,095 | Direct | |
| Mar 6, 2025 | Common shares without par value | SSaleDisposed | −91,167 | $133.82 | −$12,199,967.94 | 71,928 | Direct | |
| Mar 7, 2025 | Common shares without par value | MOption exerciseAcquired | +200 | $80.98 | +$16,196 | 72,128 | Direct | |
| Mar 7, 2025 | Common shares without par value | SSaleDisposed | −200 | $136.65 | −$27,330 | 71,928 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2025 | Common shares | MOption exerciseDisposed | −91,167 | $0.00 | $0 | 200 | Direct | |
| Mar 7, 2025 | Common shares | MOption exerciseDisposed | −200 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.